DOI: 10.1158/1538-7445.pancreatic26-a031 ISSN: 0008-5472

Abstract A031: Molecular basis of MYC-driven basal-squamous pancreatic cancer evolution

Jennifer J. Lee, Tannishtha Reya

Abstract

Basal-squamous pancreatic ductal adenocarcinoma (PDAC) is the most aggressive molecular subtype, yet the mechanisms underlying its emergence remain poorly understood. Using the Msi2-Myc mouse model, we previously demonstrated that MYC activation in Msi2+ stem-like cells is sufficient to generate basal-squamous PDAC. To define the molecular events underlying this tumorigenesis, we performed single-cell RNA sequencing of Msi2-Myc tumors. Trajectory analysis identified dynamic activation of Ly6/uPAR family members during subtype evolution, with Lypd3 selectively expressed in ΔNp63+ squamous tumor cells. Depletion of Lypd3 in mouse and human basal-squamous PDAC models significantly suppressed tumor growth in vivo. Transcriptomic analysis following Lypd3 depletion demonstrated marked suppression of MYC targets, E2F targets, and cell-cycle pathways. Together, these findings identify LYPD3 as a critical regulator required for basal-squamous tumor growth.

Citation Format:

Jennifer J. Lee, Tannishtha Reya. Molecular basis of MYC-driven basal-squamous pancreatic cancer evolution [abstract]. In: Proceedings of the AACR Conference on Pancreatic Cancer: New Frontiers in Biology and Therapeutic Development; 2026 Sep 25-28; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(18_Suppl_2):Abstract nr A031.